BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 8148637)

  • 41. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
    Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD
    Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919
    [No Abstract]   [Full Text] [Related]  

  • 42. Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia.
    Allison SK; Odderson IR
    Ultrasound Q; 2016 Sep; 32(3):302-6. PubMed ID: 26886108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin treatment of spasmodic torticollis.
    Anderson TJ; Rivest J; Stell R; Steiger MJ; Cohen H; Thompson PD; Marsden CD
    J R Soc Med; 1992 Sep; 85(9):524-9. PubMed ID: 1433117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localised autonomic failure due to botulinum toxin injection.
    Mann AC
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1320. PubMed ID: 7964804
    [No Abstract]   [Full Text] [Related]  

  • 45. Cervical dystonia following exposure to high-G forces.
    Clark JB
    Aviat Space Environ Med; 1990 Oct; 61(10):935-7. PubMed ID: 2241735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
    Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
    Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin in clinical practice.
    Hughes AJ
    Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P; Dressler D
    HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum toxin in a case of severe tardive dyskinesia mixed with dystonia.
    Stip E; Faughnan M; Desjardin I; Labrecque R
    Br J Psychiatry; 1992 Dec; 161():867-8. PubMed ID: 1362371
    [No Abstract]   [Full Text] [Related]  

  • 50. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin.
    Brin MF
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():7-23. PubMed ID: 1810210
    [No Abstract]   [Full Text] [Related]  

  • 51. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin.
    Brin MF
    Arch Neurobiol (Madr); 1991; 54(5):173-89. PubMed ID: 1804032
    [No Abstract]   [Full Text] [Related]  

  • 52. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis.
    Gelb DJ; Lowenstein DH; Aminoff MJ
    Neurology; 1989 Jan; 39(1):80-4. PubMed ID: 2642616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current status and prospects of medical therapy for dystonia].
    Osawa M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin type F for treatment of dystonia: long-term experience.
    Chen R; Karp BI; Hallett M
    Neurology; 1998 Nov; 51(5):1494-6. PubMed ID: 9818895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
    Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
    Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spasmodic torticollis: medical and botulinum A toxin treatment.
    Lee MC
    Yonsei Med J; 1992 Dec; 33(4):289-93. PubMed ID: 1364066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The botulinum toxins in the treatment of cervical dystonia.
    Brashear A
    Semin Neurol; 2001; 21(1):85-90. PubMed ID: 11346029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.